Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lysine demethylase 5B (KDM5B): A potential anti-cancer drug target
Yi‐Chao Zheng, Jiao Chang, Lin-Chen Wang, et al.
European Journal of Medicinal Chemistry (2018) Vol. 161, pp. 131-140
Closed Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Post‐translational modifications of histones: Mechanisms, biological functions, and therapeutic targets
Ruiqi Liu, Jiajun Wu, H. Henry Guo, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 110
Combination Therapy and Dual-Target Inhibitors Based on LSD1: New Emerging Tools in Cancer Therapy
Liang Shen, Bo Wang, ShaoPeng Wang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 2, pp. 922-951
Closed Access | Times Cited: 17
Histone demethylase KDM5B licenses macrophage-mediated inflammatory responses by repressing Nfkbia transcription
Yunkai Zhang, Ying Gao, Yuyu Jiang, et al.
Cell Death and Differentiation (2023) Vol. 30, Iss. 5, pp. 1279-1292
Open Access | Times Cited: 19
Emerging of lysine demethylases (KDMs): From pathophysiological insights to novel therapeutic opportunities
Sarder Arifuzzaman, Mst Reshma Khatun, R Khatun
Biomedicine & Pharmacotherapy (2020) Vol. 129, pp. 110392-110392
Open Access | Times Cited: 43
Targeting Epigenetic Regulators with Covalent Small-Molecule Inhibitors
Yi Zhang, Deqin Rong, Bingbing Li, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 12, pp. 7900-7925
Closed Access | Times Cited: 38
KDM5B promotes tumorigenesis of Ewing sarcoma via FBXW7/CCNE1 axis
Binbin Chen, Huimou Chen, Suying Lü, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 4
Open Access | Times Cited: 23
Histone Demethylase KDM5B as a Therapeutic Target for Cancer Therapy
Anmi Jose, Gautham G. Shenoy, Gabriel Rodrigues, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2121-2121
Open Access | Times Cited: 37
KDM5B promotes self‐renewal of hepatocellular carcinoma cells through the microRNA‐448–mediated YTHDF3/ITGA6 axis
Juncheng Guo, Zhuo Liu, Yijun Yang, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 25, Iss. 13, pp. 5949-5962
Open Access | Times Cited: 30
Pharmacological inhibition of KDM5A for cancer treatment
Guan‐Jun Yang, Jia Wu, Miao Liang, et al.
European Journal of Medicinal Chemistry (2021) Vol. 226, pp. 113855-113855
Closed Access | Times Cited: 28
Genetic heterogeneity within collective invasion packs drives leader and follower cell phenotypes
Elizabeth L. Zoeller, Brian Pedro, Jessica Konen, et al.
Journal of Cell Science (2019) Vol. 132, Iss. 19
Open Access | Times Cited: 35
Discovery of pyrazole derivatives as cellular active inhibitors of histone lysine specific demethylase 5B (KDM5B/JARID1B)
Bing Zhao, Qianqian Liang, Hongmei Ren, et al.
European Journal of Medicinal Chemistry (2020) Vol. 192, pp. 112161-112161
Closed Access | Times Cited: 32
Targeting histone demethylase KDM5B for cancer treatment
Yun-Dong Fu, Ming-Jie Huang, Jia–Wen Guo, et al.
European Journal of Medicinal Chemistry (2020) Vol. 208, pp. 112760-112760
Closed Access | Times Cited: 30
Drug discovery of histone lysine demethylases (KDMs) inhibitors (progress from 2018 to present)
Xingrui He, Hang Zhang, Yingqian Zhang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 231, pp. 114143-114143
Closed Access | Times Cited: 19
The Clinically Used Iron Chelator Deferasirox Is an Inhibitor of Epigenetic JumonjiC Domain-Containing Histone Demethylases
Martin Roatsch, Inga Hoffmann, Martine I. Abboud, et al.
ACS Chemical Biology (2019) Vol. 14, Iss. 8, pp. 1737-1750
Open Access | Times Cited: 27
Discovery of Novel Pyrazole-Based KDM5B Inhibitor TK-129 and Its Protective Effects on Myocardial Remodeling and Fibrosis
Kai Tang, Le-Min Jiao, Yuruo Qi, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 19, pp. 12979-13000
Closed Access | Times Cited: 16
LncRNA GAS5 suppresses TGF-β1-induced transformation of pulmonary pericytes into myofibroblasts by recruiting KDM5B and promoting H3K4me2/3 demethylation of the PDGFRα/β promoter
Yichun Wang, Diyu Chen, Han Xie, et al.
Molecular Medicine (2023) Vol. 29, Iss. 1
Open Access | Times Cited: 9
The SUMOylation and ubiquitination crosstalk in cancer
Kailang Li, Yongming Xia, Jian He, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 17, pp. 16123-16146
Closed Access | Times Cited: 9
Quantitative and time-resolved miRNA pattern of early human T cell activation
Caroline Diener, Martin Hart, Tim Kehl, et al.
Nucleic Acids Research (2020) Vol. 48, Iss. 18, pp. 10164-10183
Open Access | Times Cited: 21
Genome analysis reveals hepatic transcriptional reprogramming changes mediated by enhancers during chick embryonic development
Xi Sun, Yumeng Wang, Chaohui Wang, et al.
Poultry Science (2023) Vol. 102, Iss. 4, pp. 102516-102516
Open Access | Times Cited: 8
IKAROS in Acute Leukemia: A Positive Influencer or a Mean Hater?
Maria Rosa Conserva, Immacolata Redavid, Luisa Anelli, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3282-3282
Open Access | Times Cited: 8
Lysine demethylase 5B suppresses CC chemokine ligand 14 to promote progression of colorectal cancer through the Wnt/β-catenin pathway
Guoqiang Yan, Shiquan Li, Meng Yue, et al.
Life Sciences (2020) Vol. 264, pp. 118726-118726
Closed Access | Times Cited: 17
Hypoxia Stimulates SUMOylation-Dependent Stabilization of KDM5B
Bingluo Zhou, Yiran Zhu, Wenxia Xu, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 15
Epigenetic Mechanisms Underlying Melanoma Resistance to Immune and Targeted Therapies
Andrey Rubanov, Pietro Berico, Eva Hernando
Cancers (2022) Vol. 14, Iss. 23, pp. 5858-5858
Open Access | Times Cited: 10
<p>microRNA-139-3p Inhibits Malignant Behaviors of Laryngeal Cancer Cells via the KDM5B/SOX2 Axis and the Wnt/β-Catenin Pathway</p>
Yifei Ma, Zili Chen, Guodong Yu
Cancer Management and Research (2020) Vol. Volume 12, pp. 9197-9209
Open Access | Times Cited: 11
Transcriptional Regulation of Genes by Ikaros Tumor Suppressor in Acute Lymphoblastic Leukemia
Pavan Kumar Dhanyamraju, Soumya Iyer, Gayle Smink, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 4, pp. 1377-1377
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top